Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Ultrasound (EUS) and PET-CT Based Follow-up of Patients Radically Resected for Cancer of the Oesophagus, Stomach or Pancreas.

NCT02209415 is registered in ClinicalTrials.gov with Michael Bau Mortensen as lead sponsor.

NCT NCT02209415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02209415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Ultrasound (EUS) and PET-CT Based Follow-up of Patients Radically Resected for Cancer of the Oesophagus, Stomach or Pancreas.
Lead sponsor
Michael Bau Mortensen
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2011
Completion date
August 31, 2016
Enrollment
182 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, pancreatic cancer, stomach cancer